An assessment of different DNA delivery systems for protection against respiratory syncytial virus infection in the murine model: Gene-gun delivery induces IgG in the lung

Vaccine

Volumn 22, Issue 19, 2004, Pages 2438-2443

  Tree, Julia A ^a   Bembridge, Gary ^b   Hou, Sam ^c   Taylor, Geraldine ^b   Fashola Stone, Elizabeth ^a   Melero, José ^d   Cranage, Martin P ^a,e  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^c EDWARD JENNER INST FOR VACC RES   (United Kingdom)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

DNA vaccine; Lung antibodies; Respiratory syncytial virus

Indexed keywords

IMMUNOGLOBULIN G; PLASMID DNA; POLYGLACTIN;

ANTIBODY BLOOD LEVEL; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; FEMALE; GENE GUN; GENE TARGETING; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION;

ANIMALS; CELL LINE; DRUG DELIVERY SYSTEMS; FEMALE; IMMUNOGLOBULIN G; LUNG DISEASES; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; T-LYMPHOCYTES, CYTOTOXIC; TH2 CELLS; VACCINATION; VACCINES, DNA; VIRAL PROTEINS;

EID: 2942625680     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.11.069     Document Type: Conference Paper

References (34)

1. Heilman C.A. From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses. J. Infect. Dis. 161:1990;402-406
2. Henderson F.W., Collier A.M., Clyde W.A. Jr., Denny F.W. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N. Engl. J. Med. 300:1979;530-534
3. Falsey A.R., Walsh E.E. Humoral immunity to respiratory syncytial virus infection in the elderly. J. Med. Virol. 36:1992;39-43
4. Hussell O.P.J.T. The effect of IL-12 treatment on vaccine-enhanced illness during infection with respiratory syncytial virus. Dev. Biol. Stand. 92:1998;179-185
5. Siegrist C.A. Potential advantages and risks of nucleic acid vaccines for infant immunization. Vaccine. 15:1997;798-800
6. del Canho R., Grosheide P.M., Mazel J.A., Heijtink R.A., Hop W.C., Gerards L.J., et al. Ten-year neonatal hepatitis B vaccination program. The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine. 15:1997;1624-1630
7. Hassett D.E., Zhang J., Whitton J.L. Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge. J. Virol. 71:1997;7881-7888
8. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278-2284
9. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:1996;6119-6125
10. Raz E., Tighe H., Sato Y., Corr M., Dudler J.A., Roman M., et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5141-5145
11. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., et al. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468
12. Wolff J.A., Ludtke J.J., Acsadi G., Williams P., Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1:1992;363-369
13. Li X., Sambhara S., Li C.X., Ewasyshyn M., Parrington M., Carerini J., et al. Protection against respiratory syncytial virus infection by DNA immunization. J. Exp. Med. 188:1998;681-688
14. Martinez X., Li X., Kovarik J., Klein M., Lambert P.H., Siegrist C.A. Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice. Eur. J. Immunol. 29:1999;3390-3400
15. Bot A., Bot S., Garcia-Sastre A., Bona C. DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus. Viral Immunol. 9:1996;207-210
16. Wang Y., Xiang Z., Pasquini S., Ertl H.C. Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus. J. Virol. 72:1998;1790-1796
17. Ramsay A.J., Kent S.J., Strugnell R.A., Suhrbier A., Thomson S.A., Ramshaw I.A. Genetic vaccination strategies for enhanced cellular. Immunol. Rev. 171:1999;27-44
18. Klavinskis L.S., Barnfield C., Gao L., Parker S. Intra-nasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J. Immunol. 162:1999;254-262
19. Sharpe S., Hanke T., Tinsley-Bown A., Dennis M., Dowall S., McMichael A., et al. Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara. Virology. 313:2003;13-21
20. Jones DH, Partidos CD, Steward MW, Farrar GH, Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines. Behring Inst Mitt 1997;98:220-8.
21. Herrmann J.E., Chen S.C., Jones D.H., Tinsley-Bown A., Fynan E.F., Greenberg H.B., et al. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles. Virology. 259:1999;148-153
22. Chen S.C., Jones D.H., Fynan E.F., Farrar G.H., Clegg J.C., Greenberg H.B., et al. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72:1998;5757-5761
23. Bembridge G.P., Lopez J.A., Bustos R., Melero J.A., Cook R., Mason H., et al. Priming with a secreted form of fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge. J. Virol. 73:1999;10086-10094
24. Jones D.H., McBride B.W., Thornton C., O'Hagan D.T., Robinson A., Farrar G.H. Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection. Infect. Immun. 64:1996;489-494
25. Tinsley-Bown A.M., Fretwell R., Dowsett A.B. Formulation of poly(D, L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J. Control. Release. 66:2000;229-241
26. Taylor G., Stott E.J., Furze J., Ford J., Sopp P. Protective epitopes on the fusion protein of respiratory syncytial virus recognised by murine and bovine monoclonal antibodies. J. Gen. Virol. 73:1992;2217-2223
27. Bembridge G.P., Rodriguez N., Garcia-Beato R., Nicolson C., Melero J.A., Taylor G. Respiratory syncytial virus infection of gene gun vaccinated mice induces Th2-driven pulmonary eosinophilia even in the absence of sensitization to the fusion (F) or attachment (G) protein. Vaccine. 19:2000;1038-1046
28. Stott E.J., Taylor G., Ball L.A., Anderson K., Young K.K., King A.M., et al. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. J. Virol. 61:1987;3855-3861
29. Taylor G., Stott E.J., Hughes M., Collins A.P. Respiratory syncytial virus infection in mice. Infect. Immun. 43:1984;649-655
30. Gaddum R.M., Cook R.S., Wyld S.G., Lopez J.A., Bustos R., Melero J.A., et al. Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection. J. Gen. Virol. 77:1996;1239-1248
31. Fernie B.F., Ford E.C., Gerin J.L. The development of Balb/c cells persistently infected with respiratory syncytial virus: presence of ribonucleoprotein on the cell surface. Proc. Soc. Exp. Biol. Med. 167:1981;83-86
32. Taylor G., Stott E.J., Hayle A.J. Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus. J. Gen. Virol. 66:1985;2533-2538
33. O'Hagan D., Singh M., Ugozzoli M., Wild C., Barnett S., Chen M., et al. Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines. J. Virol. 75:2001;9037-9043
34. Singh M., Vajdy M., Gardner J., et al. Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity. Vaccine. 20:2001;594-602